🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and effectiveness of PD-1...
Status
Recruiting
Location
Hunan Provincal Tumor Hospital
Start Date
2019-01-30
Trial ID
NCT04144569
Treatments Being Tested
This is a prospective, multicenter, open-label, randomized, controlled Stud...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07417241
Treatments Being Tested
This is a prospective, open-label,multicenter Phase II study for evaluating...
Status
Unknown
Location
Multiple Locations
Start Date
2019-03-01
Trial ID
NCT03847818
Treatments Being Tested
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
This study investigates the efficacy and safety of trastuzumab, pyrotinib c...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10-20
Trial ID
NCT05577442
Treatments Being Tested
In phase Ib, our study is aimed to evaluate the safety and tolerance of SHR...
Status
Recruiting
Location
Fudan Cancer Hospital
Start Date
2025-01-08
Trial ID
NCT06718933
Treatments Being Tested
This is a multi-center, open-lable, prospective, randomized phase III clini...
Status
Active Not Recruiting
Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Start Date
2024-01-17
Trial ID
NCT06144944
To explore the efficacy and safety of pyrotinib combined with docetaxel reg...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2019-03
Trial ID
NCT03876587
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-15
Trial ID
NCT03997539
Treatments Being Tested